SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial - Concepedia

Concepedia

Publication | Closed Access

SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial

26

Citations

23

References

2019

Year

Shahin Merat, Shahin Merat, Amir‐Houshang Sharifi, Hossein Poustchi, Eskandar Hajiani, Abdolsamad Gharavi, Jalal Karimi, Fariborz Mansour‐Ghanaei, Mohammad Reza Fattahi, Lida Ahmadi,

Clinical Infectious Diseases

Abstract

NCT03200184.

References

	Year	Citations

Page 1